A Study to See Whether Estrogen Can Slow the Growth of Some ER Positive Breast Cancers
Phase 2
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2014-09-12
- Last Posted Date
- 2024-06-14
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 19
- Registration Number
- NCT02238808
- Locations
- 🇨🇦
Cross Cancer Institute, Edmonton, Alberta, Canada
Trial of Hypofractionated Radiation Therapy for Glioblastoma
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-08-01
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 133
- Registration Number
- NCT02206230
- Locations
- 🇨🇦
Cross Cancer Institute, Edmonton, Alberta, Canada
Studying if Adding Night Compression to Standard Care Will Have Improved Control of Lymphedema in Breast Cancer Subjects
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-07-11
- Last Posted Date
- 2021-02-21
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 120
- Registration Number
- NCT02187289
- Locations
- 🇨🇦
Mount St. Joseph Hospital/Holy Family (MSJ/HF), Vancouver, British Columbia, Canada
🇨🇦Cross Cancer Institute, Edmonton, Alberta, Canada
🇨🇦Tom Baker Cancer Centre, Calgary, Alberta, Canada
A Study to Evaluate the Good and Bad Effects of BIBF1120 in Small Cell Lung Cancer Patients Who Have Previously Benefited From First-line Platinum-based Chemotherapy
- First Posted Date
- 2014-06-02
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- AHS Cancer Control Alberta
- Registration Number
- NCT02152059
- Locations
- 🇨🇦
Cross Cancer Institute, Edmonton, Alberta, Canada
A Phase I Dose Escalation Study of Erlotinib in Combination With Theophylline
Phase 1
Terminated
- Conditions
- Interventions
- First Posted Date
- 2014-03-06
- Last Posted Date
- 2019-05-03
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 15
- Registration Number
- NCT02080078
- Locations
- 🇨🇦
Cross Cancer Institute, Edmonton, Alberta, Canada
Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the Heart
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2014-01-31
- Last Posted Date
- 2017-01-06
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 63
- Registration Number
- NCT02052102
- Locations
- 🇨🇦
Cross Cancer Institute, Edmonton, Alberta, Canada
A Study for Patients With Prostate Cancer to See Whether Delivering an Extra Dose of Radiation to Parts of the Body With More Cancer is Better Than Standard Treatment in Which the Same Dose of Radiation is Given Throughout the Prostate Gland
- First Posted Date
- 2013-12-09
- Last Posted Date
- 2021-02-01
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 21
- Registration Number
- NCT02004418
- Locations
- 🇨🇦
Cross Cancer Institute, Edmonton, Alberta, Canada
Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate
- First Posted Date
- 2013-11-27
- Last Posted Date
- 2024-01-30
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 83
- Registration Number
- NCT01996696
- Locations
- 🇨🇦
Prairie Mountain Health - Western Manitoba Cancer Centre, Brandon, Manitoba, Canada
🇨🇦CancerCare Manitoba, Winnipeg, Manitoba, Canada
🇨🇦Cross Cancer Institute, Edmonton, Alberta, Canada
Comparison Study of Family Practice Interventions for Depression in Adults
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-11-03
- Last Posted Date
- 2020-07-30
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 1489
- Registration Number
- NCT01975207
A Trial to Assess the Safety and Effectiveness of Lutetium-177 Octreotate Therapy in Neuroendocrine Tumours
- First Posted Date
- 2013-06-13
- Last Posted Date
- 2024-01-30
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 500
- Registration Number
- NCT01876771
- Locations
- 🇨🇦
Cross Cancer Institute, Edmonton, Alberta, Canada
© Copyright 2024. All Rights Reserved by MedPath